Inventor · disambiguated record
Michael F. Princiotta
Also filed as: PRINCIOTTA MICHAEL · PRINCIOTTA MICHAEL F
3 granted patents·12 pending applications·9 citations·filing 2016–2023
63Inventor score
Top patents by PatentIndex Score
15 records- 0190US10900044B2Listeria-based compositions comprising a peptide minigene expression system and methods of use thereofADVAXIS INC·Filed 2016·Granted Jan 26, 2021·6 cites·30 claims
- 0289US11702664B2Listeria-based compositions comprising a peptide minigene expression system and methods of use thereofADVAXIS INC·Filed 2020·Granted Jul 18, 2023·2 cites·18 claims
- 0374US2023357781A1Listeria-based compositions comprising a peptide minigene expression system and methods of use thereofADVAXIS INC·Filed 2023·Application pending·0 cites
- 0471US11897927B2Immunogenic compositions targeting recurrent cancer mutations and methods of use thereofADVAXIS INC·Filed 2017·Granted Feb 13, 2024·1 cites·74 claims
- 0567US2022378889A1Neo-epitope vaccines and methods of treating cancerEPIVAX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0665US2022362365A1Improved compositions and methods for shared neo-epitope vaccinesEPIVAX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0764US2024124540A1Immunogenic compositions targeting recurrent cancer mutations and methods of use thereofADVAXIS INC·Filed 2023·Application pending·0 cites
- 0859US2021154280A1Neo-epitope vaccines and methods of treating cancerEPIVAX ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0959US2021145951A1Compositions and methods for shared neo-epitope vaccinesEPIVAX ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1050US2022125900A1Neoantigens in cancerRICHARD GUILHEM·Filed 2021·Application pending·0 cites
- 1143US2019248856A1Listeria-Based Immunogenic Compositions Comprising Wilms Tumor Protein Antigens And Methods Of Use ThereofADVAXIS INC·Filed 2017·Application pending·0 cites
- 1240US2019032064A1Personalized Delivery Vector-Based Immunotherapy and Uses ThereofADVAXIS INC·Filed 2017·Application pending·0 cites
- 1340US2021177955A1Immunogenic heteroclitic peptides from cancer-associated proteins and methods of use thereofADVAXIS INC·Filed 2018·Application pending·0 cites
- 1437US2018305702A1Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And TreatmentADVAXIS INC·Filed 2016·Application pending·0 cites
- 1534US2019381160A1Personalized delivery vector-based immunotherapy and uses thereofADVAXIS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael F. Princiotta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →